TrivarX Limited Awaits Key Study Results, Halts Trading
Company Announcements

TrivarX Limited Awaits Key Study Results, Halts Trading

TrivarX Limited (AU:TRI) has released an update.

TrivarX Limited has requested an immediate trading halt pending an announcement about the results of their Phase 2 SAMDE study. The halt is in effect until the announcement is made or until market opening on Wednesday, 31 July 2024. The company has not provided further details regarding the reasons for the halt.

For further insights into AU:TRI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskTrivarX’s AI Tool Shows Promise in Depression Screening
TipRanks Australian Auto-Generated NewsdeskFIL Limited Boosts Stake in TrivarX Limited
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!